In the 1-month landmark analyses, the cumulative incidence rates of total DILI (log-rank P = .008) (Figure 3A) and ALT (log-rank P = .034) (Figure 3B) were significantly higher in the metabolic disorder group than in their counterpart. This evidence concerns the gene GPT and metabolic disease.